Cancer Basics: What Actually Goes Wrong at the Cellular Level

Cancer is more than cells dividing too quickly. Cancer cells acquire several abnormal capabilities that help them survive, expand and sometimes spread. The cancer type, stage, grade and biological features shape what a diagnosis means.

Cancer is a family of diseases Cancer is a large group of related diseases, not one uniform condition. It can begin in almost any tissue or in blood forming cells. Cancer develops when a cell and its descendants acquire changes that disrupt several normal controls. These changes affect growth, survival, location and interactions with surrounding tissue. Uncontrolled division is useful shorthand, but it is not the complete mechanism. A cell that divides abnormally may still be removed, contained or prevented from forming disease. Normal tissues use several controls Normal cells respond to signals that regulate when they grow, divide, specialise and die. They also respond to boundaries created by neighbouring cells and supporting tissue. Damaged cells may repair their DNA, stop dividing or enter a controlled process called programmed cell death. Immune responses can also recognise and remove some abnormal cells. Cancer cells acquire combinations of abilities that weaken these safeguards. The exact combination differs between cancers and can change as a cancer evolves. Cancer cells may continue growing, resist cell death, alter their metabolism, recruit a blood supply or avoid some immune control. Some also gain the ability to invade or spread. Not every cancer cell has every feature. Cancer biology is variable, and these abilities can emerge at different times. Cancer involves changes in DNA and gene control A genetic alteration is a change affecting DNA or how a gene functions. Cancer usually develops after several relevant alterations accumulate within a cell and its descendants. Some alterations are inherited from a parent. Most arise during life through cell division errors, ageing, infections or environmental exposures. An inherited alteration can increase susceptibility without making cancer inevitable. Environmental and behavioural risk factors also change probability rather than identify one person's cause. Cancer should not be treated as proof that someone made a harmful choice. Many people develop cancer without one identifiable cause. The time course varies. Some cancers develop slowly over many years, while others appear and progress more quickly. Tumour does not always mean cancer A tumour is an abnormal mass of tissue. A tumour can be benign or malignant, and some non cancerous swellings are not true tumours. A benign tumour does not invade nearby tissue or metastasise. It can still cause serious problems through pressure, bleeding, hormone production or its location. A malignant tumour is cancerous and has the capacity to invade tissue. Some malignant tumours also metastasise, but not every cancer has spread when found. Not every cancer forms a solid tumour. Leukaemias arise in blood forming tissue and usually involve abnormal cells in blood and bone marrow rather than one solid mass. Abnormal cells can also be confined above a tissue boundary. Terms such as carcinoma in situ describe selected non invasive abnormalities that may need treatment because some can progress. A precursor or in situ change is not proof that invasive cancer will develop. The risk depends on the specific condition and its biological features. Local invasion and metastasis are different Local invasion means cancer cells cross normal tissue boundaries and grow into nearby structures. This can disrupt function even without distant spread. Metastasis is the process by which cancer cells establish disease at a distant body site. Cells may travel through blood, lymph or another anatomical route. The primary cancer is the site and cell type where the cancer began. A distant deposit is a secondary or metastatic cancer of that same origin. For example, breast cancer that spreads to bone remains metastatic breast cancer. It does not become primary bone cancer. Metastasis is a complex process, and many released cells do not establish a new growth. Not every malignant cancer metastasises. Some cancers can still be dangerous through local invasion, blockage, bleeding or disruption of essential tissue. Type, grade and stage answer different questions The cancer type describes the cell or tissue of origin and its biological classification. Two cancers in the same organ may belong to different types. A biopsy removes cells or tissue for laboratory examination. Pathology means examining those cells and tissues to identify disease. In most solid cancers, pathology establishes the definitive cellular diagnosis. Some blood cancers are diagnosed using blood, bone marrow and specialised cell or gene tests. Diagnosis does not always require a solid tissue biopsy. Grade describes how abnormal the cancer cells and tissue organisation look under a microscope. It gives an estimate of likely behaviour, but it is not a certainty. Stage describes the extent of cancer in the body. It can include the primary tumour, nearby lymph nodes and distant spread, depending on the staging system. Grade and stage are not interchangeable. A small high grade cancer and a larger low grade cancer provide different information. A biomarker is a measurable feature of cancer cells or the body. Biomarkers can provide information about cancer biology or likely treatment response. One test rarely gives the complete picture A scan can show a mass, its location and possible spread. A scan usually cannot identify the exact cell type by itself. A biopsy can identify cellular features but may sample only part of a tumour. Pathologists combine appearance, protein markers and sometimes genetic tests. Staging may use examination, imaging, pathology, laboratory tests or procedures. Not every person needs every possible scan. Clinicians combine these findings with the person's health and priorities. The general word cancer is only the starting point for a more specific explanation. The surrounding tissue also matters Cancer cells interact with blood vessels, immune cells, connective tissue and chemical signals around them. This surrounding tumour microenvironment can restrain or support growth. Inflammation can contribute to some cancers, but it is not a universal cause. Immune responses can also recognise and limit cancer cells. Cancer is therefore not simply a group of isolated cells dividing on their own. It is an evolving process involving cells and their environment. A new breast lump example An adult notices a new breast or chest lump. Most breast lumps are not cancer, but a new lump or unusual change should be assessed by a GP. At a breast clinic, assessment may include examination, a breast X ray called mammography, ultrasound and a needle biopsy. Not every person needs every test. Imaging shows where the abnormality is and helps describe it. The biopsy determines whether cancer cells are present and identifies important cellular features. If invasive breast cancer is confirmed, pathology can report the type, grade and selected protein biomarkers. Further tests are chosen according to the findings. Staging tests estimate how far the cancer has extended. They are not automatically required in the same form for every breast cancer. The specialist team combines the type, stage, grade, biomarkers and the person's health when discussing treatment and outlook. When to seek assessment See a GP if you notice a new breast or armpit lump or another unusual breast or chest change. Most changes are not cancer, but assessment is important. See a GP for other persistent or unexplained changes, such as unusual bleeding, a changing lump or unexplained weight loss. These symptoms have many possible causes. Do not use a normal scan, blood test or screening result to dismiss a new persistent symptom. Screening and diagnostic assessment answer different questions. This lesson explains general cancer biology. It cannot diagnose cancer, predict an individual outcome or interpret a lump, scan, biopsy or pathology report.

Cancer develops when cells acquire a combination of changes that disrupt normal controls on growth, survival and tissue boundaries. Solid cancers may invade and sometimes metastasise, while blood cancers may follow a different pattern.